Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Lynde

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Journal of Cutaneous Medicine and Surgery|April 25, 2006
Efalizumab: integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasisCharles Lynde
Journal of Drugs in Dermatology : JDD|December 30, 2008
Moisturizers for the treatment of inflammatory skin conditionsCharles Lynde
Journal of Cutaneous Medicine and Surgery|March 21, 2009
Use of biologic therapeutics in difficult-to-treat psoriasisCharles Lynde
Archives of Drug Information|November 17, 2009
Impact of Desloratadine on Symptoms and Quality of Life in Subjects with Chronic Idiopathic Urticaria: A Multicenter, Practice-based StudyHarold Kim, Charles Lynde
Journal of Cutaneous Medicine and Surgery|August 8, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With PsoriasisMatthew Ladda, Charles Lynde, Patrick Fleming
Journal of Cutaneous Medicine and Surgery|September 4, 2019
Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic DisordersLyn Guenther, Charles Lynde, Yves Poulin
F1000Research|March 8, 2016
Advances in Understanding and Managing Chronic UrticariaYasmin Moolani, Charles Lynde, Gordon Sussman
Journal of Cutaneous Medicine and Surgery|September 11, 2020
A Call for Critical Analysis of TeledermatologyAnthony Zara, Patrick Fleming, Charles Lynde
Canadian Family Physician Medecin De Famille Canadien|August 13, 2021
The COVID-19 pandemic and its skin effectsAnthony Zara, Patrick Fleming, Kyle Lee, et al.
Journal of Cutaneous Medicine and Surgery|January 7, 2014
Clinical features of external genital wartsCharles Lynde, Ronald Vender, Marc Bourcier, et al.
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Journal of Cutaneous Medicine and Surgery|April 25, 2006
Efalizumab: integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasisCharles Lynde
Journal of Drugs in Dermatology : JDD|December 30, 2008
Moisturizers for the treatment of inflammatory skin conditionsCharles Lynde
Journal of Cutaneous Medicine and Surgery|March 21, 2009
Use of biologic therapeutics in difficult-to-treat psoriasisCharles Lynde
Archives of Drug Information|November 17, 2009
Impact of Desloratadine on Symptoms and Quality of Life in Subjects with Chronic Idiopathic Urticaria: A Multicenter, Practice-based StudyHarold Kim, Charles Lynde
Journal of Cutaneous Medicine and Surgery|August 8, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With PsoriasisMatthew Ladda, Charles Lynde, Patrick Fleming
Journal of Cutaneous Medicine and Surgery|September 4, 2019
Off-Label Use of Topical Calcineurin Inhibitors in Dermatologic DisordersLyn Guenther, Charles Lynde, Yves Poulin
F1000Research|March 8, 2016
Advances in Understanding and Managing Chronic UrticariaYasmin Moolani, Charles Lynde, Gordon Sussman
Journal of Cutaneous Medicine and Surgery|September 11, 2020
A Call for Critical Analysis of TeledermatologyAnthony Zara, Patrick Fleming, Charles Lynde
Canadian Family Physician Medecin De Famille Canadien|August 13, 2021
The COVID-19 pandemic and its skin effectsAnthony Zara, Patrick Fleming, Kyle Lee, et al.
Journal of Cutaneous Medicine and Surgery|January 7, 2014
Clinical features of external genital wartsCharles Lynde, Ronald Vender, Marc Bourcier, et al.
Pageof 15